Published in Blood on May 01, 1983
High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med (1986) 2.37
Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene. J Exp Med (1989) 1.83
Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med (1985) 1.72
Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest (1985) 1.58
Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex. Proc Natl Acad Sci U S A (1987) 1.57
Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence. Nucleic Acids Res (1985) 1.40
Interleukin 1 gene expression in adult T cell leukemia. J Clin Invest (1987) 1.36
Retrovirus-induced expression of interleukin 2 receptors on cells of human B-cell lineage. Proc Natl Acad Sci U S A (1984) 1.10
Molecular cloning and structure of the human interleukin 2 receptor gene. Nucleic Acids Res (1985) 1.09
Interleukin 2 inhibits in vitro growth of human T cell lines carrying retrovirus. J Exp Med (1985) 1.08
Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus. Ann Rheum Dis (1989) 1.01
HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains. Oncogene (2013) 0.94
Rat lymphoid cell lines producing human T cell leukemia virus. II. Constitutive expression of rat interleukin 2 receptor. J Exp Med (1985) 0.91
Studies on interleukin 2 receptor expression and IL-2 production by murine T cell lymphomas. Br J Cancer (1985) 0.83
Close association between interleukin 2 receptor mRNA expression and human T cell leukemia/lymphoma virus type I viral RNA expression in short-term cultured leukemic cells from adult T cell leukemia patients. J Clin Invest (1988) 0.82
Constitutive IL-2 expression in HTLV-I-infected leukaemic T cell lines. Clin Exp Immunol (1991) 0.81
Immunoelectron-microscopic localization of Tac antigen in adult T-cell leukemia/lymphoma. Am J Pathol (1985) 0.79
Cell receptors for the mammalian reovirus: reovirus-specific T-cell hybridomas can become persistently infected and undergo autoimmune stimulation. J Virol (1986) 0.78
Phenotypic evolution of CTL B-lines in vitro. Br J Exp Pathol (1987) 0.75
Interleukin 2 exerts autocrine stimulation on murine T-cell leukaemia growth. Br J Cancer (1997) 0.75
A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol (1981) 10.92
Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood (1977) 10.69
A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (1982) 9.42
Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science (1989) 5.08
Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature (1984) 4.95
Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci U S A (1986) 4.61
Persistent oxidative stress in cancer. FEBS Lett (1995) 3.85
Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J (1999) 3.70
Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem (1999) 3.67
Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem (1998) 3.44
Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res (1992) 3.22
AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A (1997) 3.21
TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol (1985) 3.18
Redox regulation of cellular activation. Annu Rev Immunol (1997) 3.17
Expression of Tac antigen on activated normal human B cells. J Exp Med (1984) 2.76
Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. Proc Natl Acad Sci U S A (1987) 2.65
Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood (1981) 2.53
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta (2001) 2.41
Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer (1982) 2.39
Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol (1989) 2.31
Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol (1996) 2.30
The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci U S A (1987) 2.22
Lymphocytes bearing Fc receptors for IgE. I. Presence of human and rat T lymphocytes with Fc epsilon receptors. J Immunol (1979) 2.20
Reconstitution of functional receptor for human interleukin-2 in mouse cells. Nature (1986) 2.14
Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells. J Immunol (1984) 2.08
Rickettsia japonica sp. nov., the etiological agent of spotted fever group rickettsiosis in Japan. Int J Syst Bacteriol (1992) 2.01
Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem (1999) 1.99
A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J Immunol (1991) 1.92
Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med (1999) 1.84
Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem (1999) 1.83
Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. Proc Natl Acad Sci U S A (1987) 1.78
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun (2000) 1.76
Adult T cell leukemia. Histological classification and characteristics. Acta Pathol Jpn (1979) 1.74
Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med (1985) 1.72
Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci U S A (1990) 1.72
Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem Biophys Res Commun (1992) 1.66
Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging. Metabolism (2000) 1.63
Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ (2005) 1.62
Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann's thrombasthenia and multiple anti-platelet antibodies. Vox Sang (1991) 1.60
The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med (1996) 1.59
Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest (1985) 1.58
Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex. Proc Natl Acad Sci U S A (1987) 1.57
Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry (2001) 1.56
Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res (2000) 1.54
Hemophagocytic syndrome in five patients with Epstein-Barr virus negative B-cell lymphoma. Cancer (1998) 1.52
Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci U S A (1999) 1.50
Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet (1998) 1.49
Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare. Leuk Res (1995) 1.48
Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J Mol Cell Immunol (1985) 1.48
Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res (2000) 1.48
Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett (1994) 1.47
Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol Today (1992) 1.47
Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J Clin Invest (1996) 1.44
Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J Biol Chem (2001) 1.43
Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound (1986) 1.43
Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res (1995) 1.43
Lymphocytes bearing Fc receptors for IgE. II. Induction of Fcepsilon-receptor bearing rat lymphocytes by IgE. J Immunol (1979) 1.43
Murine interleukin 2 receptor beta chain: dysregulated gene expression in lymphoma line EL-4 caused by a promoter insertion. Proc Natl Acad Sci U S A (1990) 1.42
Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfection. Mol Biol Med (1984) 1.41
IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol (2000) 1.41
Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol (1991) 1.40
Elevated serum levels of IL-8 in patients with HIV infection. Clin Exp Immunol (1993) 1.40
Regulatory role of IgE-binding factors from rat T lymphocytes. II. Glycoprotein nature and source of IgE-potentiating factor. J Immunol (1980) 1.40
Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence. Nucleic Acids Res (1985) 1.40
Induction of Fc epsilon-receptor bearing cells in vitro in human peripheral lymphocytes. J Immunol (1980) 1.39
[The first report of the rickettsial infections of spotted fever group in Japan: three clinical cases]. Kansenshogaku Zasshi (1985) 1.39
Competitive induction of erythroid progenitors by relative concentration of BPA to erythropoietin: possible existence of intermediate compartment between BFU-E and CFU-E. Biomed Pharmacother (1988) 1.39
Gestational trophoblastic disease in women aged 50 or more. Gynecol Oncol (1985) 1.38
Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells). J Immunol (1986) 1.37
Regulatory role of IgE-binding factors from rat T lymphocytes. III. IgE-specific suppressive factor with IgE-binding activity. J Immunol (1980) 1.36
"Congestion index" of the portal vein. AJR Am J Roentgenol (1986) 1.34
The inhibitory effects of quaternary ammonium methacrylates on soluble and matrix-bound MMPs. J Dent Res (2011) 1.33
Regulatory role of IgE-binding factors from rat T lymphocytes. I. Mechanism of enhancement of IgE response by IgE-potentiating factor. J Immunol (1980) 1.33
Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol (2000) 1.32
Lymphocytes bearing Fc receptors for IgE. IV. Formation of IgE-binding factor by rat T lymphocytes. J Immunol (1980) 1.32
Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry (2000) 1.31
Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex. Free Radic Biol Med (2001) 1.30
Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med (1998) 1.30